Sep 2026
Real-World Outcomes of Ocrelizumab and Ofatumumab Treatment in Pediatric-Onset Multiple Sclerosis.
Vivien X. Xie Cherng, C. Har, H. Roper et al.
· Paediatric drugs · 0 citations
1 paper indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.